GLOBAL RESEARCH ARCHIVE
Q2'26 Trends & JefData: Expert checks on Orb are positive
Research evidence excerpt
Q2'26 Trends & JefData: Expert checks on Orb are positive
Adyen N.V. (ADYEN NA)
Equity Research
June 19, 2026
The Long View: Adyen
Investment Thesis Risk/Reward - 12 Month View
• Unique unified technology platform provides cost and product capability
Upside : Downside
advantages to Adyen. 2000 1.92 : 1
• Class-leading unit economics and returns on capital. 1800
• Ample opportunity from core merchant acquiring business via new 1600 1605 (+78%)
merchant wins, deeper penetration of existing, and virtualisation (local 1400
acquiring).
1200 1166 (+29%)
• Additional medium- to long-term opportunities from ramping products
(issuing, embedded finance).
• We see take-rate erosion as positive given that it points to higher volume
(-40%) with existing merchants, i.e., deeper penetration and improved total 600 539
customer profitability. 400 2025 2026 +12 mo.
• We see Adyen as best positioned for a long-term growth opportunity in
Payments.
Base Case, Upside Scenario, Downside Scenario,
€1166, +29% €1605, +78% €539, -40%
• Adyen's revenue growth remains stable in low • Adyen manages to bounce back to our Adyen's TPV growth decelerates to a 15% CAGR
20s over the medium term previous growth expectations, as lost share through 2030E, due to failed merchant adoption
• 2023 operating margin marks the trough, as is regained along with expansion into new of new products and increased competition...
growth opportunities from new product and verticals and geographies (e.g., India) • ...Driving average EBITDA margin down, due to
geographic expansion come through • Operating margin gradually expands through lower contribution margin from new hires and
• Implied 2025-30E TPV CAGR = 17% 2026, as new products (embedded finance) failed traction in recent product launches
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer